This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Singh H, Otley AR, Vutcovici M, El-Matary W, Nguyen GC, Griffiths AM, et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: Distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol. 2017;112(7):1120–1134. doi:10.1038/ajg.2017.97 MedlineBenchimolEIBernsteinCNBittonACarrollMWSinghHOtleyARVutcoviciMEl-MataryWNguyenGCGriffithsAMTrends in epidemiology of pediatric inflammatory bowel disease in Canada: Distributed network analysis of multiple population-based provincial health administrative databasesAm J Gastroenterol2017112(7):1120–1134. doi:10.1038/ajg.2017.97MedlineOpen DOISearch in Google Scholar
Gosiewski T, Salamon D, Szopa M, Sroka A, Malecki MT, Bulanda M. Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes – a pilot study. Gut Pathog. 2014;6(1):43. doi:10.1186/s13099–014–0043-z MedlineGosiewskiTSalamonDSzopaMSrokaAMaleckiMTBulandaMQuantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes – a pilot studyGut Pathog20146(1):43. doi:10.1186/s13099–014–0043-zMedlineOpen DOISearch in Google Scholar
Gosiewski T, Strus M, Fyderek K, Kowalska-Duplaga K, Wedrychowicz A, Jedynak-Wasowicz U, Sladek M, Pieczarkowski S, Adamski P, Heczko PB. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2012;54(1):20–27. doi:10.1097/MPG.0b013e31822d53e5 MedlineGosiewskiTStrusMFyderekKKowalska-DuplagaKWedrychowiczAJedynak-WasowiczUSladekMPieczarkowskiSAdamskiPHeczkoPBHorizontal distribution of the fecal microbiota in adolescents with inflammatory bowel diseaseJ Pediatr Gastroenterol Nutr201254(1):20–27. doi:10.1097/MPG.0b013e31822d53e5MedlineOpen DOISearch in Google Scholar
Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, et al. REACH Study Group. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children. Gastroenterology. 2007;132(3):863–873. doi:10.1053/j.gastro.2006.12.003 MedlineHyamsJCrandallWKugathasanSGriffithsAOlsonAJohannsJLiuGTraversSHeuschkelRMarkowitzJREACH Study Group. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in childrenGastroenterology2007132(3):863–873. doi:10.1053/j.gastro.2006.12.003MedlineOpen DOISearch in Google Scholar
Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science. 2012;336(6086):1314–1317. doi:10.1126/science.1221789 MedlineIlievIDFunariVATaylorKDNguyenQReyesCNStromSPBrownJBeckerCAFleshnerPRDubinskyMInteractions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitisScience2012336(6086):1314–1317. doi:10.1126/science.1221789MedlineOpen DOISearch in Google Scholar
Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489–1499. doi:10.1053/j.gastro.2014.02.009 MedlineKosticADXavierRJGeversDThe microbiome in inflammatory bowel disease: current status and the future aheadGastroenterology2014146(6):1489–1499. doi:10.1053/j.gastro.2014.02.009MedlineOpen DOISearch in Google Scholar
Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho K-L, Veres G, Russell RK, Paerregaard A, et al.; European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795–806. doi:10.1097/MPG.0000000000000239 MedlineLevineAKoletzkoSTurnerDEscherJCCucchiaraSde RidderLKolhoK-LVeresGRussellRKPaerregaardAEuropean Society of Pediatric Gastroenterology, Hepatology, and NutritionESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescentsJ Pediatr Gastroenterol Nutr201458(6):795–806. doi:10.1097/MPG.0000000000000239MedlineOpen DOISearch in Google Scholar
Li Q, Wang C, Tang C, He Q, Li N, Li J. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s disease. J Clin Gastroenterol. 2014;48(6):513–523. doi:10.1097/MCG.0000000000000035 MedlineLiQWangCTangCHeQLiNLiJDysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s diseaseJ Clin Gastroenterol201448(6):513–523. doi:10.1097/MCG.0000000000000035MedlineOpen DOISearch in Google Scholar
McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease. Gut. 1990;31(5): 536–538. doi:10.1136/gut.31.5.536 MedlineMcKenzieHMainJPenningtonCRParrattDAntibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s diseaseGut199031(5): 536–538. doi:10.1136/gut.31.5.536MedlineOpen DOISearch in Google Scholar
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140–6736(17)32448–0 MedlineNgSCShiHYHamidiNUnderwoodFETangWBenchimolEIPanaccioneRGhoshSWuJCYChanFKLWorldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesLancet2017390(10114):2769–2778. doi:10.1016/S0140–6736(17)32448–0MedlineOpen DOISearch in Google Scholar
Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, et al.; European Crohn’s and Colitis Organisation; European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohn’s Colitis. 2014; 8(10):1179–1207. doi:10.1016/j.crohns.2014.04.005 MedlineRuemmeleFMVeresGKolhoKLGriffithsALevineAEscherJCAmil DiasJBarabinoABraeggerCPBronskyJEuropean Crohn’s and Colitis Organisation; European Society of Pediatric Gastroenterology, Hepatology and NutritionConsensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s diseaseJ Crohn’s Colitis20148(10):1179–1207. doi:10.1016/j.crohns.2014.04.005Medline24909831Open DOISearch in Google Scholar
Salamon D, Sroka-Oleksiak A, Kapusta P, Szopa M, Mrozińska S, Ludwig-Slomczyńska AH, Wolkow PP, Bulanda M, Klupa T, Malecki MT, et al. Characteristics of the gut microbiota in adult patients with type 1 and 2 diabetes based on the analysis of a fragment of 16S rRNA gene using next-generation sequencing. Polish Arch Intern Med. 2018;128:336–343. doi:10.20452/pamw.4246 MedlineSalamonDSroka-OleksiakAKapustaPSzopaMMrozińskaSLudwig-SlomczyńskaAHWolkowPPBulandaMKlupaTMaleckiMTCharacteristics of the gut microbiota in adult patients with type 1 and 2 diabetes based on the analysis of a fragment of 16S rRNA gene using next-generation sequencingPolish Arch Intern Med2018128336–343. doi:10.20452/pamw.4246 Medline29657308Open DOISearch in Google Scholar
Scarpellini E, Ianiro G, Attili F, Bassanelli C, De Santis A, Gasbarrini A. The human gut microbiota and virome: potential therapeutic implications. Dig Liver Dis. 2015;47(12):1007–1012. doi:10.1016/j.dld.2015.07.008 MedlineScarpelliniEIaniroGAttiliFBassanelliCDe SantisAGasbarriniAThe human gut microbiota and virome: potential therapeutic implicationsDig Liver Dis201547(12):1007–1012. doi:10.1016/j.dld.2015.07.008Medline718561726257129Open DOISearch in Google Scholar
Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039–1048. doi:10.1136/gutjnl-2015–310746 MedlineSokolHLeducqVAschardHPhamHPJegouSLandmanCCohenDLiguoriGBourrierANion-LarmurierIFungal microbiota dysbiosis in IBDGut201766(6):1039–1048. doi:10.1136/gutjnl-2015–310746MedlineOpen DOISearch in Google Scholar
Standaert-Vitse A, Jouault T, Vandewalle P, Mille C, Seddik M, Sendid B, Mallet JM, Colombel JF, Poulain D. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn’s disease. Gastroenterology. 2006;130(6):1764–1775. doi:10.1053/j.gastro.2006.02.009 MedlineStandaert-VitseAJouaultTVandewallePMilleCSeddikMSendidBMalletJMColombelJFPoulainDCandida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn’s diseaseGastroenterology2006130(6):1764–1775. doi:10.1053/j.gastro.2006.02.009Medline16697740Open DOISearch in Google Scholar
Standaert-Vitse A, Sendid B, Joossens M, François N, Vandewalle-El Khoury P, Branche J, Van Kruiningen H, Jouault T, Rutgeerts P, Gower-Rousseau C, et al. Candida albicans colonization and ASCA in familial Crohn’s disease. Am J Gastroenterol. 2009;104(7):1745–1753. doi:10.1038/ajg.2009.225 MedlineStandaert-VitseASendidBJoossensMFrançoisNVandewalle-El KhouryPBrancheJVan KruiningenHJouaultTRutgeertsPGower-RousseauCCandida albicans colonization and ASCA in familial Crohn’s diseaseAm J Gastroenterol2009104(7):1745–1753. doi:10.1038/ajg.2009.225Medline19471251Open DOISearch in Google Scholar
Sugita S, Kamoi K, Ogawa M, Watanabe K, Shimizu N, Mochizuki M. Detection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 2012;250(3):391–398. doi:10.1007/s00417–011–1819–1 MedlineSugitaSKamoiKOgawaMWatanabeKShimizuNMochizukiMDetection of Candida and Aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitisGraefes Arch Clin Exp Ophthalmol2012250(3):391–398. doi:10.1007/s00417–011–1819–1MedlineOpen DOISearch in Google Scholar
Wright EK, Kamm MA, Teo SM, Inouye M, Wagner J, Kirkwood CD. Recent advances in characterizing the gastrointestinal microbiome in Crohn’s disease: a systematic review. Inflamm Bowel Dis. 2015;21:1. http://www.ncbi.nlm.nih.gov/pubmed/25844959. doi:10.1097/MIB.0000000000000382 MedlineWrightEKKammMATeoSMInouyeMWagnerJKirkwoodCDRecent advances in characterizing the gastrointestinal microbiome in Crohn’s disease: a systematic reviewInflamm Bowel Dis2015211http://www.ncbi.nlm.nih.gov/pubmed/25844959. doi:10.1097/MIB.0000000000000382Medline445090025844959Open DOISearch in Google Scholar
Zwolinska-Wcislo M, Brzozowski T, Budak A, Kwiecien S, Sliwowski Z, Drozdowicz D, Trojanowska D, Rudnicka-Sosin L, Mach T, Konturek SJ, et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J Physiol Pharmacol. 2009;60(1):107–118. MedlineZwolinska-WcisloMBrzozowskiTBudakAKwiecienSSliwowskiZDrozdowiczDTrojanowskaDRudnicka-SosinLMachTKonturekSJEffect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosaJ Physiol Pharmacol200960(1):107–118. MedlineSearch in Google Scholar
